PCOS女性子代与健康对照子代心脏代谢健康的系统综述与个体参与者数据荟萃分析
该系统综述与个体参与者数据荟萃分析纳入9项观察性研究,共1367名儿童,最终分析885名1-18岁子代,比较PCOS女性子代(OPCOS,n=298)与健康对照子代(n=587)的心脏代谢特征。调整分析显示OPCOS空腹胰岛素、胰岛素抵抗、甘油三酯及HDL胆固醇升高,出生体重降低;多重检验校正后胰岛素和甘油三酯差异失去统计学显著性。性别交互检验提示男女子代间存在差异。
要点
- OPCOS空腹胰岛素β=0.21(95%CI 0.01-0.41,P=0.05),胰岛素抵抗β=0.21(95%CI 0.01-0.42,P=0.04)。
- OPCOS甘油三酯β=0.19(95%CI 0.02-0.36,P=0.03),HDL胆固醇β=0.31(95%CI 0.08-0.54,P<0.01)。
- OPCOS出生体重较对照组降低β=-116(95%CI -195至38,P<0.01)。
核心结论
- 在PCOS女性子代中观察到心脏代谢健康改变的细微迹象。
- PCOS女性生育年龄的不利心血管特征可能除遗传易感性外影响子代健康。
- 敏感性分析显示这些差异主要见于1-18岁女性子代。
研究设计与样本
- 系统综述与个体参与者数据荟萃分析,检索PubMed、Embase及灰色文献数据库至2018年2月1日。
- 纳入9项观察性研究,共1367名儿童,来自荷兰、智利和美国;排除新生儿、重复记录及随访筛查后共885名受试者。
- 采用线性混合模型分析,以标准化β为结局。
主要发现
- 调整分析中,OPCOS(n=298)较对照组(n=587)空腹胰岛素β=0.21(95%CI 0.01-0.41,P=0.05)、胰岛素抵抗β=0.21(95%CI 0.01-0.42,P=0.04)、甘油三酯β=0.19(95%CI 0.02-0.36,P=0.03)、HDL胆固醇β=0.31(95%CI 0.08-0.54,P<0.01)升高,出生体重β=-116(95%CI -195至38,P<0.01)降低。
- 多重检验校正后,胰岛素和甘油三酯差异失去统计学显著性。
- 性别交互检验显示:女性OPCOS与女性对照的2小时空腹胰岛素估计差异βf=0.45(95%CI 0.07-0.83),男性OPCOS与男性对照的估计差异βm=-0.20(95%CI -0.58-0.19),交互检验P=0.03。
- LDL胆固醇差异在女性中较低(βf=-0.39,95%CI -0.62至0.16),男性OPCOS与男性对照相当(βm=0.27,95%CI -0.03-0.57),交互检验P<0.01;总胆固醇差异女性较低(βf=-0.31,95%CI -0.57-0.06),男性βm=0.28(95%CI -0.01-0.56),交互检验P=0.01。
- HDL胆固醇差异女性较大(βf=0.53,95%CI 0.18-0.88),男性βm=0.13(95%CI -0.05-0.31),交互检验P<0.01;代谢总和评分交互检验P<0.01,但性别单独亚组分析女性βf=-0.14(95%CI -1.05-0.77)、男性βm=0.85(95%CI -0.10-1.79)未见差异。
临床怎么用
- PCOS女性子代中可观察到心脏代谢健康改变的细微迹象。
- 敏感性分析显示差异主要见于1-18岁女性子代。
- 需低偏倚风险研究阐明母亲PCOS诊断对两性胎儿发育及儿童期的影响。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Women diagnosed with polycystic ovary syndrome (PCOS) suffer from an unfavorable cardiometabolic risk profile, which is already established by child-bearing age. OBJECTIVE AND RATIONALE: The aim of this systematic review along with an individual participant data meta-analysis is to evaluate whether cardiometabolic features in the offspring (females and males aged 1-18 years) of women with PCOS (OPCOS) are less favorable compared to the offspring of healthy controls. SEARCH METHODS: PubMed, Embase and gray literature databases were searched by three authors independently (M.N.G., M.A.W and J.C.) (last updated on 1 February 2018). Relevant key terms such as 'offspring' and 'PCOS' were combined. Outcomes were age-specific standardized scores of various cardiometabolic parameters: BMI, blood pressure, glucose, insulin, lipid profile and the sum scores of various cardiometabolic features (metabolic sum score). Linear mixed models were used for analyses with standardized beta (β) as outcome. OUTCOMES: Nine relevant observational studies could be identified, which jointly included 1367 children: OPCOS and controls, originating from the Netherlands, Chile and the USA. After excluding neonates, duplicate records and follow-up screenings, a total of 885 subjects remained. In adjusted analyses, we observed that OPCOS (n = 298) exhibited increased plasma levels of fasting insulin (β = 0.21(95%CI: 0.01-0.41), P = 0.05), insulin-resistance (β = 0.21(95%CI: 0.01-0.42), P = 0.04), triglycerides (β = 0.19(95%CI: 0.02-0.36), P = 0.03) and high-density lipoprotein (HDL)-cholesterol concentrations (β = 0.31(95%CI: 0.08-0.54), P < 0.01), but a reduced birthweight (β = -116(95%CI: -195 to 38), P < 0.01) compared to controls (n = 587). After correction for multiple testing, however, differences in insulin and triglycerides lost their statistical significance. Interaction tests for sex revealed differences between males and females when comparing OPCOS versus controls. A higher 2-hour fasting insulin was observed among female OPCOS versus female controls (estimated difference for females (βf) = 0.45(95%CI: 0.07 to 0.83)) compared to the estimated difference between males ((βm) = -0.20(95%CI: -0.58 to 0.19)), with interaction-test: P = 0.03. Low-density lipoprotein-cholesterol differences in OPCOS versus controls were lower among females (βf = -0.39(95%CI: -0.62 to 0.16)), but comparable between male OPCOS and male controls (βm = 0.27(95%CI: -0.03 to 0.57)), with interaction-test: P < 0.01. Total cholesterol differences in OPCOS versus controls were also lower in females compared to the difference in male OPCOS and male controls (βf = -0.31(95%CI: -0.57 to 0.06), βm = 0.28(95%CI: -0.01 to 0.56), interaction-test: P = 0.01). The difference in HDL-cholesterol among female OPCOS versus controls (βf = 0.53(95%CI: 0.18-0.88)) was larger compared to the estimated mean difference among OPCOS males and the male controls (βm = 0.13(95%CI: -0.05-0.31), interaction-test: P < 0.01). Interaction test in metabolic sum score revealed a significant difference between females (OPCOS versus controls) and males (OPCOS versus controls); however, sub analyses performed in both sexes separately did not reveal a difference among females (OPCOS versus controls: βf = -0.14(95%CI: -1.05 to 0.77)) or males (OPCOS versus controls: βm = 0.85(95%CI: -0.10 to 1.79)), with P-value < 0.01. WIDER IMPLICATIONS: We observed subtle signs of altered cardiometabolic health in OPCOS. Therefore, the unfavorable cardiovascular profile of women with PCOS at childbearing age may-next to a genetic predisposition-influence the health of their offspring. Sensitivity analyses revealed that these differences were predominantly observed among female offspring aged between 1 and 18 years. Moreover, studies with minimal risk of bias should elucidate the influence of a PCOS diagnosis in mothers on both sexes during fetal development and subsequently during childhood.
引用
- Gunning MN, Sir Petermann T, Crisosto N, et al. Cardiometabolic health in offspring of women with PCOS compared to healthy controls: a systematic review and individual participant data meta-analysis. Hum Reprod Update. 2020. PMID: 31867675. doi:10.1093/humupd/dmz036
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。